ARCHIVES

Advisors approve set-aside for alternative medicine “best case series.”

This article is from The Cancer Letter archive.

Vol. 30 No. 44 | November 19, 2004

Download PDF Visit The Full Archive

Related Articles

Phase III Alimta Trial Fails To Extend Progression-Free Survival Without Grade 4 Adverse Events

June 28, 2013

Cediranib Demonstates Control In Alveolar Soft Part Sarcoma

May 31, 2013

ASCO to form commission to study tobacco problem.

January 23, 2004

Colorado Center Delays New Core Grant Application

July 13, 1979

ACCC T Discuss Personnel, Fund Sources, Clinical Research At Annual Meeting

January 9, 1976

Eight Scientists Receive $800,000 From Milken

January 12, 1990